share_log

毕得医药(688073.SH):实际控制人戴岚提议公司再次回购股份

Bidang Pharmaceutical (688073.SH): The actual controller Dai Lan has proposed that the company repurchase shares again.

Gelonghui Finance ·  Nov 25 16:50

Gelonghui November 25th | BeiDeYao (688073.SH) announced that the board of directors of the company received a letter from Ms. Dai Lan, the actual controller, chairman, and general manager of the company, on November 24, 2024, proposing Shanghai Beideyao Medical Technology Co., Ltd. to repurchase the company's shares, Ms. Dai Lan proposed that the company repurchase some of the RMB ordinary shares (A shares) issued by the company through the trading system of the Shanghai Stock Exchange through centralized bidding trading method, repurchase shares for the company's stock-based incentive or employee stock ownership plan, or cancel and reduce the company's registered capital. The total amount of repurchase funds shall not be less than RMB 50 million (inclusive) and not exceed RMB 100 million (inclusive).

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment